CLINICAL_TRIALS
withdrawal
· 2017-03-24
Clinical Trial Update: The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems? [NA]
Summary
A clinical trial investigating memantine as an adjunct to electroconvulsive therapy for major depressive disorder has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jerrry L Lewis | Conditions: Major Depressive Disorder | NA | Status: WITHDRAWN